Cancer remains a significant risk to human health. Nanomedicine is a new multidisciplinary
field that is garnering a lot of interest and investigation. Nanomedicine shows great potential …

Dendritic cell (DC)‐based cancer immunotherapy has exhibited remarkable clinical
prospects because DCs play a central role in initiating and regulating adaptive immune …

Induction of immunogenic cell death (ICD) plays crucial roles in cancer immunotherapy,
whereas its efficacy is severely compromised by redundant antioxidant defenses in cancer …

Human lectins are involved in a wide variety of biological processes, both physiological and
pathological, which have attracted the interest of the scientific community working in the …

In recent years, the main quest of science has been the pioneering of the groundbreaking
biomedical strategies needed for achieving a personalized medicine. Ribonucleic acids …

The complexity and diversity of biomacromolecules make them a unique class of building
blocks for generating precise assemblies. They are particularly available to a new …

Cancer immunotherapy harnesses the immune system to attack tumors and has received
extensive attention in recent years. Cancer vaccines as an important branch of …

Cancer vaccines aim at generating cytotoxic CD8+ T cells that kill cancer cells and confer
durable tumor regression. Hereto, CD8+ peptide epitopes should be presented by antigen …

Carbohydrate-binding proteins (lectins) play vital roles in cell recognition and signaling,
including pathogen binding and innate immunity. Thus, targeting lectins, especially those on …

The failure of immune responses to vaccines and dysfunctional immune responses to viral
infection, tumor development, or neoantigens lead to chronic viral infection, tumor …